Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland

Authors :: Kenfak-Foguena, A
Schöni-Affolter, F
Bürgisser, P
Witteck, A
Darling, K E A
Kovari, H
Kaiser, L
Evison, J M
Elzi, L
Gurter-De La Fuente, V
Jost, J
Moradpour, D
Abravanel, F
Izpopet, J
Cavassini, M
Kenfak-Foguena, A
Schöni-Affolter, F
Bürgisser, P
Witteck, A
Darling, K E A
Kovari, H
Kaiser, L
Evison, J M
Elzi, L
Gurter-De La Fuente, V
Jost, J
Moradpour, D
Abravanel, F
Izpopet, J
Cavassini, M
Source :: Kenfak-Foguena, A; Schöni-Affolter, F; Bürgisser, P; Witteck, A; Darling, K E A; Kovari, H; Kaiser, L; Evison, J M; Elzi, L; Gurter-De La Fuente, V; Jost, J; Moradpour, D; Abravanel, F; Izpopet, J; Cavassini, M (2011). Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerging Infectious Diseases, 17(6):1074-8.
Publication Year :: 2011
Abstract: We screened 735 HIV-infected patients in Switzerland with unexplained alanine aminotransferase elevation for hepatitis E virus (HEV) immunoglobulin G. Although HEV seroprevalence in this population is low (2.6%), HEV RNA can persist in patients with low CD4 cell counts. Findings suggest chronic HEV infection should be considered as a cause of persistent alanine aminotransferase elevation.

Database :: OAIster
Journal :: Kenfak-Foguena, A; Schöni-Affolter, F; Bürgisser, P; Witteck, A; Darling, K E A; Kovari, H; Kaiser, L; Evison, J M; Elzi, L; Gurter-De La Fuente, V; Jost, J; Moradpour, D; Abravanel, F; Izpopet, J; Cavassini, M (2011). Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerging Infectious Diseases, 17(6):1074-8.
Notes :: application/pdf, info:doi/10.5167/uzh-55556, English
Publication Type :: Electronic Resource
Accession number :: edsoai.ocn781835890
Document Type :: Electronic Resource

Tools